{
    "id": 3654,
    "fullName": "DDR2 act mut",
    "impact": "unknown",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "DDR2 act mut indicates that this variant results in a gain of function in the Ddr2 protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 4921,
        "geneSymbol": "DDR2",
        "terms": [
            "DDR2",
            "MIG20a",
            "NTRKR3",
            "TKT",
            "TYRO10",
            "WRCN"
        ]
    },
    "variant": "act mut",
    "createDate": "03/10/2015",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1807,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Lucitanib (E-3810) decreased DDR2 phosphorylation, and inhibited proliferation and induced apoptosis in lung squamous cell carcinoma cells harboring a DDR2 activating mutation in culture (PMID: 24696502).",
            "molecularProfile": {
                "id": 3456,
                "profileName": "DDR2 act mut"
            },
            "therapy": {
                "id": 1029,
                "therapyName": "Lucitanib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 199,
                    "pubMedId": 24696502,
                    "title": "Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24696502"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3456,
            "profileName": "DDR2 act mut",
            "profileTreatmentApproaches": [
                {
                    "id": 1222,
                    "name": "DDR2 inhibitor",
                    "profileName": "DDR2 act mut"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}